Pharmaceutical / Drug Definition :
Increases sodium and water excretion by inhibiting sodium reabsorption in distal tubules; promotes excretion of chloride, potassium, magnesium, and bicarbonate. Also may produce arteriolar dilation, reducing blood pressure.
In the United States, Hydrochlorothiazide is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Hydrochlorothiazide.
FDA Label Requirements and Exceptions
FDA Import Information
Hydrochlorothiazide (Hydrochlorothiazide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Hydrochlorothiazide (Hydrochlorothiazide Suppliers)
- Processors Hydrochlorothiazide
- Repackers Hydrochlorothiazide
- Relabelers Hydrochlorothiazide
- Exporters Hydrochlorothiazide
- Importers Hydrochlorothiazide
For more information about Hydrochlorothiazide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.